Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moderna Therapeutics IncfiledCriticalModerna Therapeutics Inc
Publication of AR105431A1publicationCriticalpatent/AR105431A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Los aspectos de la descripción hacen referencia a vacunas de ácidos nucleicos. Las vacunas incluyen uno o más polinucleótidos de ARN con un marco abierto de lectura que codifica uno o más antígenos de Chikungunya, uno o más antígenos del virus Zika y uno o más antígenos del Dengue. Asimismo se describen métodos de preparación y uso de tales vacunas.Aspects of the description refer to nucleic acid vaccines. Vaccines include one or more RNA polynucleotides with an open reading frame encoding one or more Chikungunya antigens, one or more Zika virus antigens and one or more Dengue antigens. Methods of preparation and use of such vaccines are also described.
ARP160102215A2015-07-212016-07-21
VACCINES FOR INFECTIOUS DISEASES
AR105431A1
(en)